Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

retinal vein occlusion/albumina

O link é salvo na área de transferência
ArtigosTestes clínicosPatentes
7 resultados

Increased fibrinogen to albumin ratio in ischemic retinal vein occlusions.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE To demonstrate the relationship between ischemia and plasma fibrinogen and serum albumin levels in cases of retinal vein occlusion (RVO). METHODS This study included 44 patients with central RVO (CRVO), 68 patients with branch RVO (BRVO), and 54 age- and sex-matched controls, for a total

[Increase of erythrocyte aggregation in retinal vein occlusion].

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Erythrocyte aggregation is one of the principal determinants of blood viscosity at low shear rates (low flow). Anatomical and hemodynamical characteristics make retinal venous circulation particularly dependent on hemorheological factors. Erythrocyte aggregation and other laboratory parameters

Intravitreal thrombin activity is elevated in retinal vein occlusion.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
To evaluate whether intravitreal thrombin activity is elevated in eyes with branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO) in comparison to healthy controls. Prospective clinical case series of 19 patients with BRVO, 13 patients suffering from CRVO and nine

Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE To identify possible risk factors for central retinal vein occlusion (CRVO). METHODS Between May 1, 1986, and December 31, 1990, 258 patients with CRVO and 1142 controls were identified at five clinical centers. Data were obtained through interviews, clinical examinations, and laboratory

Age-related changes in venous endothelial phenotype at human retinal artery-vein crossing points.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE To investigate the venous endothelial phenotype at retinal artery-vein (AV) crossings and age-related changes in human cadaveric eyes. METHODS Eighteen human donor eyes free of known ocular diseases were divided into two groups according to age (≤30 and >50 years). The central retinal

Barrier activity of fractionated human serum.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE Breakdown of the blood-retinal barrier is a major cause of visual loss in diseases such as diabetic retinopathy, age-related macular degeneration and retinal vein occlusion. METHODS Human serum, fractionated by gel filtration, was screened for factors that enhance barrier activity by
OBJECTIVE To establish a role for vascular endothelial growth factor (VEGF) during the onset and clinical course of neovascularization of the iris (NVI) in ischemic central retinal vein occlusion. METHODS Sixteen patients with ischemic central retinal vein occlusion were followed up for 12 months by
Junte-se à nossa
página do facebook

O mais completo banco de dados de ervas medicinais apoiado pela ciência

  • Funciona em 55 idiomas
  • Curas herbais apoiadas pela ciência
  • Reconhecimento de ervas por imagem
  • Mapa GPS interativo - marcar ervas no local (em breve)
  • Leia publicações científicas relacionadas à sua pesquisa
  • Pesquise ervas medicinais por seus efeitos
  • Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas

Google Play badgeApp Store badge